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Available online xxxxObjectives: The aim of this study was to investigate the subclinical myocardial affection in prediabetics with the
evaluation of left ventricular (LV) systolic strain and strain rate by speckle tracking echocardiography (STE), and
atrial electromechanical delay.
Study design: Global Longitudinal strain (GLS) and strain rate (GLSR) were assessed by STE, and Intra- and
interatrial electromechanical delay (EMD) were measured utilizing tissue Doppler imaging (TDI) in 108 pre-
diabetic patients and 72 age and gender matched healthy volunteers.
Results: The GLS (−19.4 ± 2.8 vs. 23.8 ± 2.1%; p b 0.001) and GLSR () were signiﬁcantly lower in prediabetics
when compared with the healthy control. Pre-diabetic patients had signiﬁcantly prolonged PA lateral, PA septum
and PA tricuspid. The intra- (PA septum-PA tricuspid) and interatrial (PA lateral-PA tricuspid) electromechanical
delays were prolonged compared to controls (p b 0.0001, p b 0.05, p b 0.001, and p b 0.002, respectively). The
GLS%, GLSR and atrial electromechanical delay were highly signiﬁcantly correlated with fasting blood glucose,
andmodestly correlated to systolic blood pressure, total cholesterol, triglycerides, and left ventricularmass index.
Conclusion: GLS%; GLSR assessed by STE was decreased; intra- and interatrial electromechanical delays were
prolonged, in pre-diabetic subjects. These non-invasive indices broaden the spectrum of subclinical myocardial
dysfunction in pre-diabetic patients.
© 2016 Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Dysfunction1. Introduction
The frequency of cardiovascular disease is increased in diabetic pa-
tients, including ischemic heart disease, systolic and/or diastolic heart
failure.Moreover, although cardiac involvement is often clinically silent,
cardiovascularmortality is higher in diabetic patients [1]. There are sev-
eral studies showing that left ventricular (LV) diastolic function may be
impaired in diabetic patients [2,3]. Additionally, it is well-established
that left atrial (LA) mechanical functions play a signiﬁcant role in main-
taining LV stroke volume in patients with impaired LV diastolic function
[4]. Atrial ﬁbrillation (AF) is the most common type of tachyarrhythmia
encountered in clinical practice and is associated with increased mor-
bidity and mortality [5].
Conventional and tissue Doppler echocardiography measurements
have major disadvantages such as angle dependence, limited spatial
resolution, and deformation analysis in one dimension [6,7]. The recent
development of two-dimensional (2D) speckle tracking echocardiogra-
phy (STE) overcomes someof these limitations and is used for the quan-
titative assessment of global and local LV function from 2D images [8]., Zagazig University Hospital,
Moustafa).
is an open access article under the CPrevious studies have indicated that 2DSTE is more sensitive than con-
ventional echocardiography for detecting subclinical ventricular dys-
function in various clinical disorders [9,10].
Pre-diabetes deﬁnes patients at high risk for diabetes in the future
with impaired fasting glucose (IFG; fasting glucose above 100 mg/dL)
and/or impaired glucose tolerance (IGT; 2 h oral glucose tolerance test
[OGTT] levels of 140––200 mg/dL) and hemoglobin A1c (HbA1c) of a
level of 5.7% to 6.4% [11].
The IFG and IGT should not be considered only as clinical symptoms,
but should be regarded as risk factors for both diabetes and cardiovascu-
lar diseases [12]. Not only diabetes, but also all stages of glucose abnor-
malities are associated with an increased risk of cardiovascular
morbidity and mortality, making it important to identify such condi-
tions as early as possible [13].
We hypothesized that subclinical cardiac dysfunction begins early in
all diabetic spectrum even in pre-diabetic state. So the purpose of this
studywas to evaluate atrial electromechanical coupling, LAmechanical
functions and ventricular functions in pre-diabetic patients.
2. Patients and methods
The study included 108 consecutive patients (63 males, 45 females;
mean age 49.3 ± 11.5 years) the pre-diabetic group who had no overtC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Clinical characteristics of the two groups.
Pre-diabetics (n = 108) Control (n = 72) p Value
Age (years) 52.7 ± 8.2 51.6 ± 7.1 N0.05
Gender (female) 50 30 N0.05
SBP (mm Hg) 132 ± 14 118 ± 11 N0.05
DBP (mm Hg) 82 ± 11 78 ± 8 N0.05
Heart rate (beat/min) 79 ± 22 71 ± 12 N0.05
BMI (kg/m2) 27.5 ± 4.1 26.2 ± 4.2 N0.05
FBG (mg/dL) 123 ± 5.8 89 ± 7.1 b0.001
OGTT level 179 ± 22 123 ± 16 b0.0001
HbA1c (%) 6.1 ± 1.3 4.9 ± 1.02 b0.01
TC (mg/dL) 199 ± 46 165 ± 31 b0.001
TG (mg/dL) 169 ± 55 99 ± 38 b0.05
LDL-C (mg/dL) 125 ± 31 89 ± 34 b0.05
HDL-C (mg/dL) 45 ± 9 49 ± 8 b0.05
BMI — body mass index; DBP — diastolic blood pressure; DM— diabetes mellitus; FBG —
fasting plasma glucose; OGTT—Oral glucose tolerance test, HbA1c — glycosylated hemo-
globin; HDL-C — high density lipoprotein cholesterol; LDL-C — low density lipoprotein
cholesterol; SBP — systolic blood pressure; TC — total cholesterol; TG — triglycerides.
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and/or whose two hour glucose concentrations on an oral glucose toler-
ance test was between 140 and 200 mg/d. The control group consisted
of 72 healthy volunteers (the non-DM group, 40 male, 32 female;
mean age 46.2 ± 9.2 years) with no illnesses, whose examinations
were normal and whose laboratory values were within normal ranges.
Exclusion criteria includes subjects with a history of myocardial in-
farction, angina pectoris or other symptoms of CAD, hypertension,
those with right or left bundle branch block, Wolff-Parkinson-White
syndrome, intraventricular conduction defect on resting ECG, and
thosewith ischaemic changes on the ECG and stress test, were excluded
from the study. Moreover, patients with a history of palpitations, AF,
permanent pacemaker implantation, antiarrhythmic drug use and
those with thyroid disease, left ventricular (LV) hypertrophy or the
use any drug affecting LV function were also excluded from the study.
2.1. Conventional echocardiographic examination
Two-dimensional, M-mode pulsed and color ﬂow Doppler echocar-
diographic examinations (GE-Vivid 7; General Electric, Milwaukee,
WI, USA) with a 2.5–5 MHz phased array transducer were performed.
During echocardiography, continuous one-lead electrocardiographic re-
cordingwas obtained. M-modemeasurements and conventional Dopp-
ler echocardiographic examinations were performed according to the
guidelines of the American Society of Echocardiography [14]. Left ven-
tricular diastolic function was assessed with both conventional and tis-
sue Doppler indices. The myocardial systolic (Sm), early diastolic (Em),
and late diastolic (Am) velocities were obtained at the septal mitral an-
nulus by placing a tissue Doppler sample volume. The E/Em and Em/Am
ratios were subsequently calculated [15].
2.2. Speckle-tracking imaging
Two-dimensional speckle tracking analyses were performed on
grayscale images of the left ventricle obtained in the apical four-
chamber, two-chamber and three-chamber views. Three consecutive
end-expiratory cardiac cycles using the high frame rate (50 Hz or
more) harmonic imaging in each echocardiographic view were ac-
quired. In each view, the myocardium was automatically divided by
the software into six segments. The analyzed values within the middle
points for all resulting 18 segments were averaged to obtain the global
longitudinal strain (GLS) and the global longitudinal peak systolic strain
rate (GLSR); in accordance with current conventions GLS and GLSR
values were presented as negative (segment shortening) [16].TheFig. 1.Measurement of the PA interval with tissue Doppler imaging, (the interval from the
onset of P wave on the surface ECG to the beginning of the late diastolic wave: Am).adequacy of tracking was veriﬁed manually, and the region of interest
was readjusted to achieve optimal tracking. The segment was excluded
if no acceptable border was traced. GLS and GLSR valueswere not calcu-
lated if N1 segment per view was excluded.2.3. Atrial electromechanical coupling
Tissue Doppler echocardiography was performed with a transducer
frequency of 3.5 to 5.0MHz, adjusting the spectral pulsedDoppler signal
ﬁlters to obtain theNyquist limit of 15 to 20 cm/s, and using theminimal
optimal gain setting. The monitor sweep speed was set at 50 to
100 mm/s to optimize the spectral display of myocardial velocities. In
apical four-chamber view, the pulsed Doppler sample volume was
placed at the level of the LV lateral mitral annulus, and subsequently
at the septal mitral annulus and right ventricular tricuspid annulus.
The sampling window was positioned as parallel as possible with the
myocardial segment of interest to obtain the optimal angle of imaging.
Atrial electromechanical coupling was deﬁned as the time interval
from the onset of P wave on the surface electrocardiogram to the begin-
ning of the late diastolic wave (Am wave), i.e. PA interval wasmeasured
from the lateral mitral annulus (PA lateral), septal mitral annulus (PA
septum), and right ventricular tricuspid annulus (PA tricuspid) [17].
(Fig. 1) All PA intervals were averaged over three consecutive beats.
The difference between the lateral and tricuspid PA intervals was de-
ﬁned as interatrial electromechanical delay, and the difference between
the septal and tricuspid PA intervals was deﬁned as intra-atrial electro-
mechanical delay [18].Table 2
Echocardiographic ﬁndings of the two groups of the groups.
Pre-diabetic (n = 108) Control (n = 72) p Value
LVEDD (mm) 45.9 ± 2.5 45.2 ± 2.9 N0.05
LVESD (mm) 27.4 ± 2.1 28.4 ± 1.9 N0.05
LA (mm) 36.1 ± 3.2 34.9 ± 2.7 N0.05
AOD (mm) 31.0 ± 3.3 28.1 ± 2.9 N0.05
IVS (mm) 9.2 ± 1.1 8.9 ± 1.2 N00.5
PW (mm) 9.0 ± 1.4 8.5 ± 1.3 N0.05
EF (%) 62.8 ± 2.8 64.1 ± 2.6 N0.05
LV Mass Index (g/m2) 102.4 ± 19.3 99.3 ± 16.2 N0.05
E/A 0.88 ± 0.29 1.12 ± 0.23 b 0.05
EDT (ms) 225 ± 32 182.5 ± 26 b 0.03
LVs (cm/s) 8.95 ± 1.1 8.64 ± 1.05 N0.5
Em (cm/s) 11.2 ± 1.6 12.5 ± 1.9 N0.5
Am(cm/s) 11.0 ± 1.3 9.1 ± 1.7 N0.5
E/Em 5.3 ± 0.11 4.1 ± 0.11 b0.01
Table 5
Correlation of global longitudinal strain; strain rate and atrial electromechanical delay to
clinical and echocardiographic ﬁndings in prediabetics.
GLS% GLSR LAEMD
Age −0.201 N0.05 −0.179 N0.05 0204 N0.05
Systolic blood pressure
mmHg
−0.299 b0.05 −0.312 b0.05 0.283 b0.05
Total cholesterol (mml/dL) −0.311 b0.05 −0.307 b0.05 0.295 b0.05
Total triglycerides (ml/dL) −0273 b0.05 −0.302 b0.05 0.289 b0.05
Fasting blood sugar −0.541 b0.001 −0.495 b0.001 0.491 b0.001
EF% −0.225 N0.05 −0.196 N0.05 0215 N0.05
E/Em −0.219 N0.05 −0.235 N0.05 0229 N0.05
LV Mass Index (g/m2) −0.399 b0.01 −0.382 b0.01 0.461 b0.001
Systolic blood pressure, Total cholesterol, and total triglycerides (p b 0.05).
Table 3
Comparison of left ventricle longitudinal strain and strain rate values in prediabetics ver-
sus controls.
Pre-diabetics
(n = 108)
Control
(n = 72) p Value
Longitudinal Strain (%)
Mean Apical 4-chamber GLS% −20.3 ± 3.7 −26.8 ± 4.5 b0.001
Mean Apical 2-chamber GLS% −19.5 ± 2.4 −25.5 ± 2.9 b0.001
Mean Apical 3-chamber GLS% −19.1 ± 2.6 −21.9 ± 3.1 b0.001
Global longitudinal strain −19.4 ± 2.8 −24.8 ± 3.3 b0.001
Longitudinal Strain rate
Mean Apical 4-chamber GLSR (SRe s−1) −1.3 ± 0.2 −1.9 ± 0.7 b0.001
Mean Apical 2-chamber GLSR (SRe s−1) −1.2 ± 0.2 −1.7. ± 0.3 b0.003
Mean Apical 3-chamber GLSR (SRe s−1) −1.2 ± 0.1 −1.6. ± 0.2 b0.05
Global longitudinal strain rate (SRe s−1) −1.2 ± 0.3 −1.8 ± 0.11 b0.001
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Fasting blood glucose, total cholesterol, triglyceride, low density li-
poprotein, high density lipoprotein and HbA1c values were measured
from venous blood collected from the pre-DM and non-DM groups
after fasting for 8 h. A simpliﬁed protocol was used for OGTT. Fasting
blood glucose was determined immediately before ingestion of 75 g of
solubilized glucose, followed 2 h later by determination of 2 h plasma
glucose (2 h-PG). Patients with FBG N 100 mg/dL fulﬁlled the criteria
for IFG and those with 2 h OGTT level of 140–199 mg/dL fulﬁlled the
criteria for IGT based on the American Diabetes Association criteria. Pa-
tients with IFG and IGT were both included in the pre-DM group.
2.5. Statistical analysis
All analyses were made using the SPSS (SPSS forWindows 9.0) soft-
ware package. Continuous variables were expressed as mean ± stan-
dard deviation; categorical variables were expressed as percentages.
Categorical datawere compared with the chi-square test. Pearson's cor-
relation coefﬁcients were used to assess the strength of relationship be-
tween continuous variables. A stepwise, multiple regression analysis
was used to identify signiﬁcant determinants of interatrial electrome-
chanical delay, which included variables that correlated with a p value
of less than 0.1 in the Pearson's correlation analysis. A p value of less
than 0.05 was considered signiﬁcant.
The intraobserver variability was 3.8% for GLS, and 0.89 for GLSR,
while interobserver variability was 6.1% for GLS and 0.85 for GLSR. For
LA-EMD, intraobserver variability was 2.9(ms) for interatrial mechani-
cal delay and 1.6(ms)for intra-atrialmechanical delay,whilest the inter-
observer variability 2.4(ms) for interatrial mechanical delay and
1.5(ms)for intra-atrial mechanical delay
3. Results
Clinical characteristics and laboratory ﬁndings of the two groups are
shown in Table 1. All ﬁndings were comparable among both groupsTable 4
Atrial electromechanical coupling of the two groups.
Pre-diabetic
(n = 108)
Control
(n = 72) p Value
PA lateral (ms) 69.5 ± 11.2 51.0 ± 10.5 b0.0001
PA septum (ms) 58.7 ± 6.2 44.5 ± 6.0 b0.001
PA tricuspid (ms) 47.8 ± 7.7 39.8 ± 7.6 b0.05
PA lateral-PA tricuspid (ms)a 24.2 ± 7.5 10.0 ± 2.8 b0.001
PA septum-PA tricuspid (ms)b 10.8 ± 4.6 5.3 ± 3.2 b0.002
PA interval: the interval with tissue Doppler, from the onset of P wave on the surface elec-
trocardiogram to the beginning of the late diastolic wave.
a Interatrial mechanical delay.
b Intra-atrial mechanical delay.(p N 0.05), except lipid proﬁle where, pre-diabetic patients exhibited
signiﬁcantly higher levels than control subjects (p b 0.05). Left ventric-
ular diastolic function was signiﬁcantly impaired in pre-diabetic com-
pared to non-diabetics (E/A: p b 0.05; EDT: p b 0.03; E/E′: p b 0.01)
(Table 2). Left ventricular EF% was comparable among both groups
(p N 0.05), meanwhile, the results showed that the global longitudinal
ventricular strain (GLS) and Global longitudinal strain rate (GLSR)
were signiﬁcantly lower in prediabetics p b 0.001 (Table 3).3.1. Atrial electromechanical coupling
Tissue Doppler echocardiography ﬁndings (Table 4) showed signiﬁ-
cantly prolonged lateral, septal PA and tricuspid PA conduction times in
pre-diabetic patients, compared to the controls (p b 0.0001, b0.001 and
b0.05 respectively). Both interatrial (lateral PA-tricuspid PA) and intra-
atrial (septal PA-tricuspid PA) conduction times were delayed in the
pre-diabetic group (24.2 + 7.5 vs. 10.0 + 2.8 ms, p b 0.001;
10.8 + 4.6 vs. 5.3 + 3.2 ms, p b 0.002, respectively).
Table 5 represents the correlation analysis of GLS%, GLSR and LAEMD
with clinical and echocardiographic variables. There were highly signif-
icant correlations with fasting blood glucose (p b 0.001), and left ven-
tricular mass index (p b 0.01).
The results showed that the GLS and GLSR were signiﬁcantly associ-
atedwith LAEMD (Table 6). Fig. 2 represents the correlation of GLSwith
intraatrial electromechanical delay (r =−0.745; p b 0.001) and Fig. 3
represents the correlation of GLSR with intraatrial electromechanical
delay (r =−0.531; p b 0.001)4. Discussion
The current study revealed that in prediabetic subjects, ﬁrstly longi-
tudinal systolic strain and strain were signiﬁcantly decreased in pre-
diabetic patients compared with the healthy controls; secondly,
prolonged intra- and interatrial electromechanical delays and thirdly,
GLS, GLSR and electromechanical delay were signiﬁcantly correlatedTable 6
Correlation analysis of global strain and strain rate to parameters of atrial electromechan-
ical delay.
GLS% GLSR
r p-Value r p-Value
PA lateral-PA tricuspid (ms)a −0.637 b0.001 −0.613 b0.001
PA septum-PA tricuspid (ms)b −0.745 b0.0001 −0.531 b0.001
GLS: Global longitudinal strain; GLSR: Global longitudinal strain rate.
PA interval: the interval with tissue Doppler, from the onset of P wave on the surface elec-
trocardiogram to the beginning of the late diastolic wave.
a Interatrial mechanical delay.
b Intra-atrial mechanical delay.
Fig. 2. Correlation of global longitudinal strain with intra-atrial electromechanical delay.
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ic blood pressure and left ventricular mass index.
The ﬁndings in the current study conﬁrmed the previous results of
Geyhan, et al.'s study [19] regarding signiﬁcant impairment of left ven-
tricular longitudinal strain in prediabetics compared to control subjects;
whilest the de novo ﬁnding in the current study was a signiﬁcant corre-
lation between decreased in both GLS and GLSR with left atrial electro-
mechanical delay in prediabetics.
A primary diabetic cardiomyopathy represents a high risk factor of
heart failure in the absence of ischemic, valvular and hypertensive
heart disease in the diabetic population.[20,21] Diabetic cardiomyopa-
thy is characterized by an early left ventricular (LV) diastolic dysfunc-
tion and a late LV systolic dysfunction. The current study outline the
idea of diabetic cardiomyopathy begins early in the pre-diabetic stage
of the disease. Unquestionably, an early detection of LV damage is a
major goal for the prevention of cardiac disease in the all the spectrum
of diabetes mellitus. Several studies have reported increased intra- and
interatrial electromechanical coupling and atrial electromechanical
delay, measuredwith TDI, in patients with paroxysmal AF,mitral steno-
sis, familialMediterranean fever, and type 1 diabetesmellitus compared
with control subjects [22,23]. These data suggest that increased
interatrial electromechanical delay might be related with an increased
risk for AF [24,25]. A possible mechanism is that the atrial cell damage
may be started in the pre-diabetic stage in patients at a risk for develop-
ment of diabetesmellitus (e.g. thosewith impaired glucose intolerance)Fig. 3. Correlation of global longitudinal strain rate with intra-atrial electromechanical
delay.[26], or there is a functional disorder by changing the chemical compo-
sition of the proteins (collagenIand elastin), modiﬁcation of atrial elec-
trical and contractile properties, and changes in the amount and the
composition of the extracellular matrix, that inﬂuencing heterogeneity
of atrial conduction time and atrial refractoriness in pre-diabetic pa-
tients [27,28].
Stahrenberg et al. [29] investigated the association between glucose
metabolism and diastolic function along the whole spectrum of glucose
metabolism states in a subgroup of patients classiﬁed as normal, OGTT,
pre-diabetic, non-insulin treated or insulin-treated type 2 diabetic. They
found impaired diastolic functions in all groups, and concluded that glu-
cose metabolism is associated with diastolic dysfunction across the
whole spectrum. In another study, Gunduz et al. [30] found enhanced
PWD in patients with diastolic dysfunction,with PWD values increasing
as the degree of diastolic dysfunctionworsened. Similar to Gunduz et al.
[30], while we found impaired diastolic functions in pre-diabetic pa-
tients compared to the control group.
4.1. Clinical implication
Our ﬁndings may have important clinical implications to the early
identiﬁcation of subclinical myocardial abnormalities with normal car-
diac function at the conventional echocardiography. Regularmonitoring
subjects with prediabetes to evaluate their glycemic status should in-
clude at annual reassessment of FPG and/or an OGTT, weight gain
should be addressed and monitored at regular intervals as well as
other cardiovascular risk factors as elevated blood pressure and/or dys-
lipidemia [31,32] The early diagnosis of a subclinical myocardial dys-
function in pre-diabetic patients and electromechanical delay
assessment is useful for the appropriate clinical testing of new thera-
peutic approaches in high risk population.
5. In conclusion
Global longitudinalmyocardial systolic function assessed by STEwas
decreased; intra- and interatrial electromechanical delays were
prolonged, in pre-diabetic patients. These non-invasive indices broaden
the spectrum of subclinical myocardial dysfunction in pre-diabetic
patients.
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